<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Normobaric <z:mp ids='MP_0002319'>hyperoxia</z:mp> is under investigation as a treatment for <z:hpo ids='HP_0011009'>acute</z:hpo> ischaemic <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>In experimental models, normobaric <z:mp ids='MP_0002319'>hyperoxia</z:mp> reduces cerebral ischaemic injury and improves functional outcome </plain></SENT>
<SENT sid="2" pm="."><plain>The mechanisms of neuroprotection are still debated because, (i) inhalation of 100% O2 does not significantly increase total blood O2 content; (ii) it is not known whether normobaric <z:mp ids='MP_0002319'>hyperoxia</z:mp> increases O2 delivery to the severely ischaemic cortex because of its short diffusion distance; and (iii) <z:mp ids='MP_0002319'>hyperoxia</z:mp> may reduce collateral cerebral blood flow (CBF) to ischaemic penumbra because it can cause vasoconstriction </plain></SENT>
<SENT sid="3" pm="."><plain>We addressed these issues using real-time two-dimensional multispectral reflectance imaging and laser speckle flowmetry to simultaneously and non-invasively determine the impact of normobaric <z:mp ids='MP_0002319'>hyperoxia</z:mp> on CBF and oxygenation in ischaemic cortex </plain></SENT>
<SENT sid="4" pm="."><plain><z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">Ischaemia</z:e> was induced by distal middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (dMCAO) in normoxic (30% inhaled O2, arterial pO2 134 +/- 9 mmHg), or hyperoxic mice (100% inhaled O2 starting 15 min after dMCAO, arterial pO2 312 +/- 10 mmHg) </plain></SENT>
<SENT sid="5" pm="."><plain>Post-ischaemic normobaric <z:mp ids='MP_0002319'>hyperoxia</z:mp> caused an immediate and progressive increase in <z:chebi fb="0" ids="7861">oxyhaemoglobin</z:chebi> (oxyHb) concentration, nearly doubling it in ischaemic core within 60 min </plain></SENT>
<SENT sid="6" pm="."><plain>In addition, <z:mp ids='MP_0002319'>hyperoxia</z:mp> improved CBF so that the area of cortex with &lt; or =20% residual CBF was decreased by 45% 60 min after dMCAO </plain></SENT>
<SENT sid="7" pm="."><plain>Furthermore, <z:mp ids='MP_0002319'>hyperoxia</z:mp> reduced the frequency of peri-<z:mpath ids='MPATH_124'>infarct</z:mpath> depolarizations (<z:chebi fb="2" ids="8066">PIDs</z:chebi>) by more than 60%, and diminished their deleterious effects on CBF and metabolic load </plain></SENT>
<SENT sid="8" pm="."><plain>Consistent with these findings, <z:mpath ids='MPATH_124'>infarct</z:mpath> size was reduced by 45% in the <z:mp ids='MP_0002319'>hyperoxia</z:mp> group 2 days after 75 min transient dMCAO </plain></SENT>
<SENT sid="9" pm="."><plain>Our data show that normobaric <z:mp ids='MP_0002319'>hyperoxia</z:mp> increases tissue O2 delivery, and that novel mechanisms such as CBF augmentation, and suppression of <z:chebi fb="2" ids="8066">PIDs</z:chebi> may afford neuroprotection during <z:mp ids='MP_0002319'>hyperoxia</z:mp> </plain></SENT>
</text></document>